Eric Assénat
0000-0002-8958-2793
Publication & Citation Trends
Publications
0 total
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Cited by 0
Semantic Scholar
Descriptive analysis of outcomes in participants with combined hepatocellular-cholangiocarcinoma in the phase 3 KEYNOTE-966 trial.
Cited by 0
Semantic Scholar
The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer
Cited by 0
Semantic Scholar
Results from the safety lead-in for a phase 1b/2 study of ivosidenib plus durvalumab and gemcitabine/cisplatin as first-line therapy in patients with locally advanced, unresectable or metastatic cholangiocarcinoma with an IDH1 mutation.
Cited by 1
Semantic Scholar
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study.
Cited by 0
Semantic Scholar
GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancer
Cited by 0
Semantic Scholar
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data.
Cited by 1
Semantic Scholar
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis
Cited by 7
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(98)
Pancreatic and Hepatic Oncology Research
(66)
Colorectal Cancer Treatments and Studies
(59)
Cholangiocarcinoma and Gallbladder Cancer Studies
(46)
Cancer Genomics and Diagnostics
(41)
Affiliations
Centre National de la Recherche Scientifique
Johns Hopkins University
Inserm
Université de Montpellier
CEA Valduc